Search results for: England
Filter search results
Assessing the Use of Multi-indication Medicines: A Review of Current Data Capabilities in the UK
1 March 2015
…no country are prescriptions routinely issued with an attached diagnosis, the data linkage capabilities to infer this are the most advanced in England. However, data analysis is based on inferences…
New Methods for Modelling EQ-5D-5L Value Sets: An Application to English Data
1 January 2016
…Paper 16/01: ‘Valuing Health-Related Quality of Life: An EQ-5D-5L Value Set for England’. Please note that a revised version of this paper has been accepted for publication and is forthcoming…
Uncertainty and Risk in HTA Decision Making
1 November 2016
…of the policy documents governing cost benefit analysis and cost effectiveness analysis in respect of HTA in England and Wales, and the results of interviews with former decision makers at…
The Debate on Indication-Based Pricing in the U.S. and Five Major European Countries
5 January 2018
…payers see the potential for IBP to increase price competition in some indications, and the NHSE in England has used contracting by genotype in Hep C drug procurement to increase…
The Impact of New Medicines in the NHS: 70 Years of Innovation
1 August 2018
…economic outcomes. The NHS in England and Wales came into existence on the 5th July 1948. It provided coverage for a range of approved medical and pharmaceutical interventions. This resulted…
Securing Funds for the Proposed NHS Multi-year Funding: The Feasibility of Using a Hypothecated Tax
1 October 2018
…spending on the NHS in England for each of three years. It indicated that taxes will rise to pay for this. Debate has increased as to whether a separate (hypothecated)…
Realising The Broader Value of Vaccines in the UK: Ready for Prime Time?
1 February 2021
…the recognition of such value in England’s HTA appraisals. This status quo is worrying as it risks undervaluation and consequently underfunding of vaccines. Yet creating change in how vaccine assessments…
Making Outcome-Based Payment a Reality in the NHS. Phase Two: Practical Considerations
1 December 2021
…the National Health Service (NHS) in England was described in a 2019 report by the Office of Health Economics, RAND Europe, King’s College London and Cancer Research UK. OBP can…
2020 OHE Annual Report to the Charity Commission
1 December 2021
We are pleased to submit the third report to the Charity Commission for England and Wales, OHE’s second since becoming a registered charity in December 2016. OHE obtained its charitable…